• Sabattini S, Baldassarro VA, Zaccone R, Calzà L, Giardino L, Vascellari M, Lorenzini L, Moretti M, Marconato L. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain. Vet Comp Oncol. 2024 Mar;22(1):70-77. doi: 10.1111/vco.12949. Epub 2023 Dec 19. PMID: 38112225


• Marconato L, Aralla M, Agnoli C, Melacarne A, Sabattini S, Foglia A, Del Magno S, Diana A, Romagnoli N, Balboni A, Rescigno M. A phase 2, single-arm, open-labelclinical trial on adjuvant peptide-based anticancer vaccination in dogs with biologically aggressive hemangiosarcoma undergoing surgery and chemotherapy: preliminary results of an ongoing study. Presented orally at the VCS Mid-year-Conference, Puerto Vallarta, Mexico April 4th, 2022


• Marconato L, Tiraboschi L, Aralla M, Sabattini S, Melacarne A, Agnoli C, Balboni A, Salvi M, Foglia A, Punzi S, Romagnoli N, Rescigno M. A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers (Basel). 2023 Aug 22;15(17):4209. doi: 10.3390/cancers15174209. PMID: 37686485; PMCID: PMC10486958


• Mazzone E, Marconato L, Cascione L, Bertoni F, Aresu L. The K9 pan-cancer genome atlas to improve understanding of canine cancer genetics. Presented orally at the 77° Convegno SisVET, Parma, June 12th, 2024


• Capellero S, De Maria R, Piras L, Sapino A, Marconato L, Marchiò C, Aresu L. Ex Vivo Expansion and Characterization of Canine Monocyte-Derived Dendritic Cells: A Gateway for Delivering Cancer Neoantigens. Presented orally at the 77° Convegno SisVET, Parma, June 12th, 2024


• Marconato L, Oldani A, Sabattini S, Baldassarro VA, Zaccone R, Dondi G, Quadalti C, Calzà L, Giardino L. Brain metastasis in a model of canine haemangiosarcoma: investigating the role of miRNAs. Presented orally at the Neuroscience of Cancer, Bologna, Italy 2/4-10-2024


• Lorenzini L, Baldassarro VA, Quadalti C, Marconato L, Sannia M, Zanella L, Chirenti D, Ferraro L, Giardino L, Calzà L. How to prevent “chemobrain”: a systematic preclinical study to support predictive models for human patients. Presented orally at the Neuroscience of Cancer, Bologna, Italy 2/4-10-2024